If a patient is taking insulin lispro (Admelog) 2 units twice daily and their blood glucose remains above 10 mmol/L, can the total daily dose be increased to 6 units?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Admelog be Increased to 6 Units Per Day?

Yes, you can and should increase the Admelog dose to 6 units per day (3 units twice daily) if blood glucose remains above 10 mmol/L on 2 units twice daily, and you should continue titrating upward until glycemic targets are achieved.

Recommended Titration Approach

Based on the 2025 ADA Standards of Care, when initiating and titrating prandial insulin like Admelog (insulin lispro), the evidence-based approach is 1:

Initial dose adjustment:

  • Start with 4 units per day OR 10% of basal insulin dose (if on basal insulin)
  • Increase dose by 1-2 units or 10-15% every 3 days to reach postprandial glucose goals without hypoglycemia

For your specific scenario:

  • Current dose: 2 units twice daily (4 units total)
  • Blood glucose remains >10 mmol/L (>180 mg/dL)
  • Recommended action: Increase to 3 units twice daily (6 units total) immediately
  • Continue monitoring and titrate upward by 1-2 units per injection every 3 days until targets are met

Important Clinical Considerations

Assess the pattern of hyperglycemia first:

  • If fasting glucose is elevated → prioritize basal insulin optimization
  • If postprandial glucose is elevated → increase prandial insulin (Admelog)
  • Your patient's BG >10 mmol/L suggests inadequate prandial coverage

Hypoglycemia management protocol 1:

  • If hypoglycemia occurs: determine the cause
  • If no clear reason identified: reduce the corresponding dose by 10-20%
  • Prescribe glucagon for emergent hypoglycemia

Avoid These Common Pitfalls

  1. Therapeutic inertia: The guidelines explicitly warn against delaying dose adjustments. Reassess and modify every 3-6 months, or sooner if targets aren't met 1

  2. Inadequate titration: Don't stop at 6 units/day if glucose remains elevated. The 2023 AACE guidelines note that prandial insulin should be titrated based on individualized needs, with increases of 10-20% if pre-meal glucose remains >140 mg/dL 2

  3. Ignoring basal insulin needs: If your patient isn't on basal insulin, consider adding it. The ADA recommends starting basal insulin at 10 units/day or 0.1-0.2 units/kg/day when injectable therapy is needed 1

  4. Injection site issues: Ensure proper injection technique with 4-6mm needles, rotate sites to avoid lipohypertrophy which distorts insulin absorption 3

Monitoring Strategy

  • Check pre-meal and 2-hour postprandial glucose values
  • Titrate the morning dose based on pre-lunch/lunch glucose
  • Titrate the evening dose based on bedtime/overnight glucose
  • Target fasting plasma glucose <110 mg/dL (<6.1 mmol/L) and postprandial <180 mg/dL (<10 mmol/L)

The bottom line: 6 units/day is appropriate but likely still insufficient. Continue aggressive titration every 3 days until glycemic targets are achieved, monitoring closely for hypoglycemia.

References

Guideline

american association of clinical endocrinology consensus statement: comprehensive type 2 diabetes management algorithm - 2023 update.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2023

Research

EADSG Guidelines: Insulin Therapy in Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018

Related Questions

For a patient with HbA1c 9.6% who is taking 15 units of NPH insulin at night, how should the insulin regimen be adjusted?
A patient on basal insulin glargine (Lantus) is to be started on rapid‑acting insulin aspart (Novorapid) before meals; how should the initial mealtime dose be started and what titration schedule should be provided for home use, with blood glucose targets expressed in mmol/L?
What insulin regimen should be used for a patient requiring 8 units of rapid‑acting insulin during the day and 4 units of basal insulin at night?
For a patient with fasting glucose of 210–228 mg/dL who is currently taking insulin glargine (basal insulin) 10 U daily and has received 8 U of short‑acting insulin in the past 24 hours, what is the best way to increase the long‑acting insulin dose?
What is the appropriate dose and type (regular vs. basal) of insulin for a patient with uncontrolled diabetes and an HbA1c (Hemoglobin A1c) level of 8%?
How should I manage a 64-year-old man with intermittent low back pain after a fall two years ago, chronic nasal congestion, bleach‑induced skin burning, who smokes 1–2 cigarettes daily and has a blood pressure of 135/71 mmHg while taking amlodipine?
In an 84-year-old patient with a thickened bladder wall and a normal prostate, what is the appropriate management?
What investigations should be performed for a patient presenting with frequent spider veins on the legs?
What is the recommended management of sepsis in an adult patient?
Can the prandial insulin dose be increased to 2 units three times daily for a patient whose glucose remains >10 mmol/L on the current regimen of 2 units twice daily?
Can Depakote (valproic acid) cause anemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.